Casdin Capital as of Sept. 30, 2020
Portfolio Holdings for Casdin Capital
Casdin Capital holds 45 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invitae (NVTAQ) | 17.5 | $392M | 9.0M | 43.35 | |
| Biolife Solutions Com New (BLFS) | 7.6 | $169M | 5.8M | 28.94 | |
| Relay Therapeutics (RLAY) | 7.3 | $162M | 3.8M | 42.59 | |
| Blueprint Medicines (BPMC) | 6.4 | $144M | 1.6M | 92.70 | |
| Fate Therapeutics (FATE) | 5.5 | $122M | 3.1M | 39.97 | |
| Myokardia | 5.3 | $119M | 870k | 136.33 | |
| Alnylam Pharmaceuticals (ALNY) | 4.0 | $90M | 620k | 145.60 | |
| Twist Bioscience Corp (TWST) | 3.4 | $76M | 1.0M | 75.97 | |
| Sarepta Therapeutics (SRPT) | 3.3 | $74M | 530k | 140.43 | |
| Agios Pharmaceuticals (AGIO) | 2.7 | $61M | 1.8M | 35.00 | |
| Revolution Medicines (RVMD) | 2.5 | $57M | 1.6M | 34.80 | |
| Generation Bio | 2.2 | $50M | 1.6M | 30.91 | |
| Bluebird Bio | 2.2 | $49M | 915k | 53.95 | |
| Burning Rock Biotech Sponsored Ads | 2.2 | $48M | 1.9M | 25.08 | |
| Denali Therapeutics (DNLI) | 2.1 | $47M | 1.3M | 35.83 | |
| Codexis (CDXS) | 2.1 | $47M | 4.0M | 11.74 | |
| Caredx (CDNA) | 2.0 | $45M | 1.2M | 37.94 | |
| Pacific Biosciences of California (PACB) | 2.0 | $44M | 4.5M | 9.87 | |
| Beigene Sponsored Adr (ONC) | 1.9 | $43M | 150k | 286.44 | |
| Allogene Therapeutics (ALLO) | 1.6 | $36M | 945k | 37.71 | |
| Adaptive Biotechnologies Cor (ADPT) | 1.6 | $35M | 713k | 48.63 | |
| Adverum Biotechnologies | 1.3 | $28M | 2.8M | 10.30 | |
| Magenta Therapeutics | 1.0 | $23M | 3.3M | 6.80 | |
| Crispr Therapeutics Namen Akt (CRSP) | 1.0 | $22M | 266k | 83.64 | |
| Global Blood Therapeutics In | 1.0 | $22M | 395k | 55.14 | |
| Amyris Com New | 1.0 | $22M | 7.4M | 2.92 | |
| Constellation Pharmceticls I | 0.9 | $20M | 980k | 20.26 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.8 | $18M | 820k | 22.40 | |
| Alector (ALEC) | 0.8 | $17M | 1.7M | 10.54 | |
| Dermtech Ord ord (DMTKQ) | 0.8 | $17M | 1.4M | 11.95 | |
| Zai Lab Adr (ZLAB) | 0.7 | $16M | 190k | 83.17 | |
| Berkeley Lts | 0.7 | $15M | 200k | 76.36 | |
| Bristol-myers Squibb Right 99/99/9999 | 0.6 | $14M | 6.3M | 2.25 | |
| Fulcrum Therapeutics (FULC) | 0.5 | $11M | 1.4M | 7.93 | |
| Sangamo Biosciences (SGMO) | 0.5 | $10M | 1.1M | 9.45 | |
| Iovance Biotherapeutics (IOVA) | 0.4 | $9.5M | 290k | 32.92 | |
| Illumina (ILMN) | 0.4 | $9.3M | 30k | 309.07 | |
| Black Diamond Therapeutics (BDTX) | 0.4 | $8.7M | 289k | 30.23 | |
| Orchard Therapeutics Ads | 0.3 | $7.7M | 1.9M | 4.11 | |
| Dyne Therapeutics (DYN) | 0.3 | $7.5M | 370k | 20.19 | |
| Turning Point Therapeutics I | 0.3 | $6.6M | 75k | 87.36 | |
| Oric Pharmaceuticals (ORIC) | 0.3 | $6.3M | 252k | 25.01 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.2 | $4.3M | 140k | 30.87 | |
| Stoke Therapeutics (STOK) | 0.2 | $4.0M | 120k | 33.49 | |
| Deciphera Pharmaceuticals | 0.1 | $3.3M | 65k | 51.31 |
